REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314

Stock Information for Clearside Biomedical Inc.

Loading

Please wait while we load your information from QuoteMedia.